IP Library Granted Patent US 11,771,812
Granted Patent B2
US 11,771,812 · App. 18/121,975 · Granted Oct 3, 2023

Method and device for purification of blood from circulating cell free DNA

Inventor: Kirill Surkov (St. Petersburg, RU)
Assignee: SANTERSUS AG
A61M1/3496A61M1/3486A61M2202/0415
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,771,812
App. No.
18/121,975
Granted
Oct 3, 2023
Kind
B2
Abstract

The invention provides apheresis devices and their use for removal of substantially all types of cell free DNA (cfDNA) in patients' blood, including nucleosome-bound cfDNA, exosome-bound cfDNA and unbound cfDNA (including double stranded DNA (dsDNA), single stranded DNA (ssDNA) and oligonucleotides), to limit the negative effects of the circulating cfDNA and to treat various diseases.

Claims (3)

1. A device comprising one or more affinity matrices, wherein said one or more affinity matrices are capable of capturing nucleosome-bound cell free DNA (cfDNA), exosome-bound cfDNA, and unbound cfDNA from a bodily fluid of a subject, wherein at least one of said one or more affinity matrices comprises a linker histone.

2. The device of claim 1 , wherein the unbound cfDNA comprises dsDNA, ssDNA and oligonucleotides.

3. The device of claim 1 , wherein linker histone is human H1.3 linker histone.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 15, 2023
From: SURKOV, KIRILL
To: SANTERSUS SA
Reel/Frame 064587/0976 →
CHANGE OF ADDRESS Recorded Aug 15, 2023
From: SANTERSUS AG
To: SANTERSUS AG
Reel/Frame 064587/0980 →
CHANGE OF NAME Recorded Aug 15, 2023
From: SANTERSUS SA
To: SANTERSUS AG
Reel/Frame 064587/0985 →
Continuity (3)
Continuation 16648045
Provisional Application 62559822 · Sep 18, 2017
Related Publication 20230218810A1 · Jul 13, 2023